![](/img/cover-not-exists.png)
CTLA4Ig Administered During T-Cell Priming Suppresses De Novo Alloantibodies and Minimizes Recall Antibody Responses
WU, G.D., Kim, I., Chai, N., Jordan, S., Klein, A.S.Volume:
34
Language:
english
Journal:
The Journal of Heart and Lung Transplantation
DOI:
10.1016/j.healun.2015.01.394
Date:
April, 2015
File:
PDF, 633 KB
english, 2015